Region Area

Lawyers

Yoon Kang

Yoon Kang

Work Department

Pharmaceutical Litigation

Position

Principal

Career

With a reputation as a smart and pragmatic problem-solver, Yoon is a trusted legal advisor and leader in the life sciences industry. A Principal in the firm’s life sciences litigation practice, Yoon counsels global pharmaceutical innovators and research institutions on all aspects of patent rights, including those pertaining to small molecules and biologics inventions. Yoon’s commitment to her clients’ success is clear in her work. She has significant experience as lead counsel, representing pharmaceutical clients before the Federal Court and Federal Court of Appeal in complex patent litigation, including under the Patented Medicines (Notice of Compliance) Regulations. Yoon and her team successfully appealed to the Supreme Court of Canada on the controversial question of “promised utility.” The Supreme Court of Canada, in an important and highly anticipated decision, AstraZeneca Canada Inc v. Apotex Inc (2017 SCC 36), rejected the “promise doctrine” and clarified the requirement for patent “utility” in Canada. The unanimous decision represents an important victory for innovators seeking protection in Canada. She is a Fellow of IPIC, member and former co-Chair of the Patents and Industrial Design Committee of the CBA. BSc (Microbiology and Genetics); MSc (Molecular Biology and Medical Genetics); LLB. Registered Patent & Trademark Agent. Called to the Ontario Bar in 1995.

Memberships

Fellow, Intellectual Property Institute of Canada Member, International Association for the Protection of Intellectual Property (AIPPI) Member and past Co-Chair of the Patents and Industrial Design Committee, Canadian Bar Association

Education

Ontario Bar, 1995 Registered Trademark Agent, 1995 Registered Patent Agent, 1995 University of Toronto, LL.B., 1993 University of Toronto, M.Sc. (Molecular Biology and Medical Genetics), 1990;thesis titled Homologous recombination between transferred and chromosomal DNA: effects of linearizing the targeting vector at different sites University of Toronto, B.Sc. (Microbiology and Genetics), 1988 Registered to practise before the United States Patent and Trademark Office

Mentions

Canada

Intellectual property

Leading partner